AMCP Submits Comments to CMS on Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency

AMCP's Tom Casey gives a recap on the House Committee on Oversight and Accountability hearing, “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability.”

Slide presentation used for a webinar reviewing the AMCP 2023 AAO report.

Overview of the AMCP Access, Affordability and Outcome: The Value of Managed Care Pharmacy (AAO) report